rs587781065

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002474.3(MYH11):​c.5370C>T​(p.Leu1790=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00868 in 1,613,862 control chromosomes in the GnomAD database, including 599 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1790L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.031 ( 226 hom., cov: 32)
Exomes 𝑓: 0.0064 ( 373 hom. )

Consequence

MYH11
NM_002474.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.874
Variant links:
Genes affected
MYH11 (HGNC:7569): (myosin heavy chain 11) The protein encoded by this gene is a smooth muscle myosin belonging to the myosin heavy chain family. The gene product is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP. A chromosomal rearrangement involving this gene is associated with acute myeloid leukemia of the M4Eo subtype. Mutations in this gene are associated with visceral myopathy, megacystis-microcolon-intestinal hypoperistalsis syndrome 2, and familial thoracic aortic aneurysm 4. [provided by RefSeq, May 2022]
NDE1 (HGNC:17619): (nudE neurodevelopment protein 1) This gene encodes a member of the nuclear distribution E (NudE) family of proteins. The encoded protein is localized at the centrosome and interacts with other centrosome components as part of a multiprotein complex that regulates dynein function. This protein plays an essential role in microtubule organization, mitosis and neuronal migration. Mutations in this gene cause lissencephaly 4, a disorder characterized by lissencephaly, severe brain atrophy, microcephaly, and severe cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 16-15717274-G-A is Benign according to our data. Variant chr16-15717274-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 138351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-15717274-G-A is described in Lovd as [Benign]. Variant chr16-15717274-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.874 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0963 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH11NM_002474.3 linkuse as main transcriptc.5370C>T p.Leu1790= synonymous_variant 38/41 ENST00000300036.6 NP_002465.1
MYH11NM_001040113.2 linkuse as main transcriptc.5391C>T p.Leu1797= synonymous_variant 39/43 ENST00000452625.7 NP_001035202.1
NDE1NM_017668.3 linkuse as main transcriptc.948-6917G>A intron_variant ENST00000396354.6 NP_060138.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH11ENST00000300036.6 linkuse as main transcriptc.5370C>T p.Leu1790= synonymous_variant 38/411 NM_002474.3 ENSP00000300036 P3P35749-1
MYH11ENST00000452625.7 linkuse as main transcriptc.5391C>T p.Leu1797= synonymous_variant 39/431 NM_001040113.2 ENSP00000407821 P35749-3
NDE1ENST00000396354.6 linkuse as main transcriptc.948-6917G>A intron_variant 1 NM_017668.3 ENSP00000379642 P1Q9NXR1-2

Frequencies

GnomAD3 genomes
AF:
0.0305
AC:
4637
AN:
152194
Hom.:
226
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0988
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0128
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0548
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000514
Gnomad OTH
AF:
0.0211
GnomAD3 exomes
AF:
0.0142
AC:
3569
AN:
251040
Hom.:
164
AF XY:
0.0146
AC XY:
1980
AN XY:
135724
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0529
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000546
Gnomad OTH exome
AF:
0.00783
GnomAD4 exome
AF:
0.00641
AC:
9363
AN:
1461550
Hom.:
373
Cov.:
33
AF XY:
0.00744
AC XY:
5407
AN XY:
727090
show subpopulations
Gnomad4 AFR exome
AF:
0.104
Gnomad4 AMR exome
AF:
0.00523
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0523
Gnomad4 FIN exome
AF:
0.0000753
Gnomad4 NFE exome
AF:
0.000406
Gnomad4 OTH exome
AF:
0.0103
GnomAD4 genome
AF:
0.0305
AC:
4650
AN:
152312
Hom.:
226
Cov.:
32
AF XY:
0.0303
AC XY:
2258
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.0988
Gnomad4 AMR
AF:
0.0127
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0553
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.000514
Gnomad4 OTH
AF:
0.0204
Alfa
AF:
0.0155
Hom.:
51
Bravo
AF:
0.0343
Asia WGS
AF:
0.0250
AC:
88
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.00101

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 04, 2013Leu1797Leu in exon 39 of MYH11: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 9.9% (433/4394) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs35295469). -
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-- -
Familial thoracic aortic aneurysm and aortic dissection Benign:5
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioMar 10, 2023- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 07, 2018- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 19, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Aortic aneurysm, familial thoracic 4 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.14
DANN
Benign
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35295469; hg19: chr16-15811131; COSMIC: COSV55564139; COSMIC: COSV55564139; API